Mark Leonard Singleton - 17 Jun 2024 Form 4 Insider Report for Bioventus Inc. (BVS)

SEC form
4
Accepted by SEC
21 Jun 2024, 16:27:26 UTC
Prior SEC filing
18 Jun 2024
Next SEC filing
24 Jun 2024
Source filing
View source filing
Filing notes and source

Key filing fact

Mark Leonard Singleton filed Form 4 for Bioventus Inc. (BVS) on 21 Jun 2024.

Key facts

  • This page summarizes Mark Leonard Singleton's Form 4 filing for Bioventus Inc. (BVS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Jun 2024, 16:27.

Change

  • Previous filing in this sequence was filed on 18 Jun 2024.
  • Current net transaction value: -$80,318.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BVS transaction

Class A Common Stock

Sale

Transaction value
-$80,318
Shares
-13,753
Change %
-18%
Price
$5.84
Shares after
63,114
Date
17 Jun 2024
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Reflects shares sold to cover taxes upon the vesting of restricted stock units on June 15, 2024 pursuant to a standing 10b5-1 instruction adopted on March 15, 2024.

Footnote F2

The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $5.525 to $6.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .